Cancer and thrombosis: The platelet perspective

Frontiers in Cell and Developmental Biology

Volumn 4, Issue JAN, 2017, Pages

  Meikle, Claire K S ^a   Kelly, Clare A ^a   Garg, Priyanka ^a   Wuescher, Leah M ^a   Ali, Ramadan A ^a   Worth, Randall G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cancer; Metastasis; Platelet; TCIPA; Thrombosis

Indexed keywords

EID: 85018725543     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2016.00147     Document Type: Review

References (183)

1. Al Dieri, R., de Laat, B., and Hemker, H. C. (2012). Thrombin generation: what have we learned? Blood Rev. 26, 197-203. doi: 10.1016/j.blre.2012.06.001
2. Ali, R. A., Wuescher, L. M., and Worth, R. G. (2015). Platelets: essential components of the immune system. Curr. Trends Immunol. 16, 65-78
3. Amo, L., Tamayo-Orbegozo, E., Maruri, N., Eguizabal, C., Zenarruzabeitia, O., Rinon, M., et al. (2014). Involvment of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front. Oncol. 4:245. doi: 10.3389/fonc.2014.00245
4. Antczak, A. J., Singh, N., Gay, S. R., and Worth, R. G. (2010). IgG-complex stimulated platelets: a source of sCD40L and RANTES in initiation of inflammatory cascade. Cell. Immunol. 263, 129-133. doi: 10.1016/j.cellimm.2010.03.009
5. Antczak, A. J., Vieth, J. A., Singh, N., and Worth, R. G. (2011). Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets. Clin. Vaccine Immunol. 18, 210-216. doi: 10.1128/CVI.00296-10
6. Ardekani, A. M., and Naeini, M. M. (2010). The role of microRNAs in human diseases. Avicenna J. Med. Biotechnol. 2, 161-179
7. Aslam, R., Speck, E. R., Kim, M., Crow, A. R., Bang, K. W. A., Nestel, F. P., et al. (2006). Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo. Blood 107, 637-641. doi: 10.1182/blood-2005-06-2202
8. Assoian, R. K., and Sporn, M. B. (1983). Transforming growth factor-beta in human platelets-identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155-7160
9. Assoian, R. K., and Sporn, M. B. (1986). Type B transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102, 1217-1223. doi: 10.1083/jcb.102.4.1217
10. Bambace, N. M., and Holmes, C. E. (2011). The platelet contribution to cancer progression. J. Thromb. Haemost. 9, 237-249. doi: 10.1111/j.1538-7836.2010.04131.x
11. Bendas, G., and Borsig, L. (2012). Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int. J. Cell Biol. 2012:676731. doi: 10.1155/2012/676731
12. Bennett, J. S., Berger, B. W., and Billings, P. C. (2009). The structure and function of platelet integrins. J. Thromb. Haemost. 7, 200-205. doi: 10.1111/j.1538-7836.2009.03378.x
13. Berlacher, M. D., Vieth, J. A., Heflin, B. C., Gay, S. R., Antczak, A. J., Tasma, B. E., et al. (2013). FcyRIIa ligation induces platelet hypersensitivity to thrombotic stimuli. Am. J. Pathol. 82, 244-254. doi: 10.1016/j.ajpath.2012.09.005
14. Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., et al. (2015). RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell 28, 667-676. doi: 10.1016/j.ccell.2015.09.018
15. Bizzozero, G. (1881). Su di un nuovo elemento morfologico del sange dei mammiferi e sulla sua importanza nella trombosi e nella coagulazione. L'Osservatore. Gazz. Clin. 17, 785-787
16. Booyse, F. M., and Rafelson, M. E. (1967). Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim. Biophys. Acta 145, 188-190. doi: 10.1016/0005-2787(67)90673-9
17. Borsig, L. (2008). The role of platelet activation in tumor metastasis. Expert Rev. Anticancer Ther. 8, 1247-1255. doi: 10.1586/14737140.8.8.1247
18. Borsig, L., Wong, R., Feramsico, J., Nadeau, D. R., Varki, N. M., and Varki, A. (2001). Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. U.S.A. 98, 3352-3357. doi: 10.1073/pnas.061615598
19. Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., and Varki, A. (2002). Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. U.S.A. 99, 2193-2198. doi: 10.1073/pnas.261704098
20. Boukerche, H., Berthier-Vergnes, O., Penin, F., Tabone, E., Lizard, G., and McGregor, J. L. (1994). Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets. Br. J. Haematol. 87, 763-772. doi: 10.1111/j.1365-2141.1994.tb06736.x
21. Buergy, D., Wenz, F., Groden, C., and Brockmann, M. A. (2012). Tumor-platelet interaction in solid tumors. Int. J. Cancer 130, 2747-2760. doi: 10.1002/ijc.27441
22. Callander, N. S., Varki, N., and Rao, L. V. M. (1992). Immunohistochemical identification of tissue factor in solid tumors. Cancer 70, 1194-1201. doi: 10.1002/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E
23. Chadha, S. A., Kocak-Uzel, E., Das, P., Minsky, B. D., Delclos, M. E., Mahmood, U., et al. (2015). Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol. 54, 971-978. doi: 10.3109/0284186X.2014.1000466
24. Chen, M., and Geng, J.-G. (2006). P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch. Immunol. Ther. Exp. 54, 75-84. doi: 10.1007/s00005-006-0010-6
25. Chen, W., Zhang, Y., Yang, Y., Zhai, Z., and Wang, C. (2015). Prognostic significance of arterial and venous thrombosis in resected specimens for non-small cell lung cancer. Thromb. Res. 136, 451-455. doi: 10.1016/j.thromres.2015.06.014
26. Cognasse, F., Hamzeh, H., Chavarin, P., Acquart, S., Genin, C., and Garraud, O. (2005). Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 83, 196-198. doi: 10.1111/j.1440-1711.2005.01314.x
27. Coupland, L. A., Chong, B. H., and Parish, C. R. (2012). Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res. 72, 4662-4671. doi: 10.1158/0008-5472.CAN-11-4010
28. Cox, D., Kerrigan, S. W., and Watson, S. P. (2011). Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J. Thromb. Haemost. 9, 1097-1107. doi: 10.1111/j.1538-7836.2011.04264.x
29. Cummings, M., Merone, L., Keeble, C., Burland, L., Grzelinski, M., Sutton, K., et al. (2015). Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Br. J. Cancer 113, 311-320. doi: 10.1038/bjc.2015.200
30. Dallas, M. R., Chen, S.-H., Streppel, M. M., Sharma, S., Maitra, A., and Konstantopoulos, K. (2012). Sialofucosylated podocalyxin is a functional E-and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am. J. Physiol. Cell Physiol. 303, C616-C624. doi: 10.1152/ajpcell.00149.2012
31. Dashevsky, O., Varon, D., and Brill, A. (2009). Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int. J. Cancer 124, 1773-1777. doi: 10.1002/ijc.24016
32. Date, K., Hall, J., Greenman, J., Maraveyas, A., and Madden, L. A. (2013). Tumour and microparticle tissue factor expression and cancer thrombosis. Thromb. Res. 131, 109-115. doi: 10.1016/j.thromres.2012.11.013
33. Denis, M. M., Tolley, N. D., Bunting, M., Schwertz, H., Jiang, H., Lindemann, S., et al. (2005). Escaping the nuclear confines: signal dependent pre-mRNA splicing in anucleate platelets. Cell 122, 379-391. doi: 10.1016/j.cell.2005.06.015
34. Deryugina, E. I., and Quigley, J. P. (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34. doi: 10.1007/s10555-006-7886-9
35. Dicke, C., and Langer, F. (2015). Pathophysiology of Trousseau's syndrome. Hamostaseologie 35, 52-59. doi: 10.5482/HAMO-14-08-0037
36. Emir, S., Aydin, M., Can, G., Bali, I., Yildirim, O., Oznur, M., et al. (2015). Comparison of colorectal neoplastic polyps and adenocarcnoma with regard to NLR and PLR. Eur. Rev. Med. Pharmacol. Sci. 19, 3613-3618
37. Erpenbeck, L., and Schon, M. P. (2010). Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115, 3427-3436. doi: 10.1182/blood-2009-10-247296
38. Escolar, G., and White, J. G. (1991). The platelet open canalicular system: a final common pathway. Blood Cells 17, 467-485. discussion: 486-495
39. Escolar, G., Leistikow, E., and White, J. G. (1989). The fate of the open canalicular system in surface and suspension-activated platelets. Blood 74, 1983-1988
40. Falanga, A., Tartari, C. J., and Marchetti, M. (2012). Microparticles in tumor progression. Thromb. Res. 129, S132-S136. doi: 10.1016/S0049-3848(12)70033-6
41. Felding-Habermann, B., Habermann, R., Saldivar, E., and Ruggeri, Z. M. (1996). Role of beta-3 integrins in melanoma cell adhesion to activated platelets under flow. J. Biol. Chem. 271, 5892-5900. doi: 10.1074/jbc.271.10.5892
42. Feller, S., and Lewitzky, M. (2016). Hunting for the ultimate liquid cancer biopsy-let the TEP dance begin. Cell Commun. Signal. 14, 24. doi: 10.1186/s12964-016-0147-9
43. Feng, J.-F., Huang, Y., and Chen, Q.-X. (2014a). The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl. Oncol. 7, 632-637. doi: 10.1016/j.tranon.2014.07.009
44. Feng, J.-F., Huang, Y., and Chen, Q.-X. (2014b). Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J. Surg. Oncol. 12:58. doi: 10.1186/1477-7819-12-58
45. Ferroni, P., Riondino, S., Formica, V., Cereda, V., Tosetto, L., La Farina, F., et al. (2015). Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int. J. Cancer 136, 1234-1340. doi: 10.1002/ijc.29076
46. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186. doi: 10.1056/NEJM197111182852108
47. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., et al. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16, 183-194. doi: 10.1016/j.ccr.2009.06.017
48. Furie, B., Furie, B. C., and Flaumenhaft, R. (2001). A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb. Haemost. 86, 214-221
49. Gardiner, E. E., and Andrews, R. K. (2013). Platelets: envoys at the infection frontline. J. Infect. Dis. 208, 871-873. doi: 10.1093/infdis/jit305
50. Gardiner, E. E., and Andrews, R. K. (2014). Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus. Med. Rev. 28, 56-60. doi: 10.1016/j.tmrv.2014.03.001
51. Gay, L. J., and Felding-Habermann, B. (2011). Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11, 123-134. doi: 10.1038/nrc3004
52. Geddings, J. E., and Mackman, N. (2013). Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122, 1873-1880. doi: 10.1182/blood-2013-04-460139
53. Gidlöf, O., van der Brug, M., öhman, J., Gilje, P., Olde, B., Wahlestedt, C., and Erlinge, D. (2013). Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121, 3908. doi: 10.1182/blood-2012-10-461798
54. Goubran, H. A., Burnouf, T., Radosevic, M., and El-Ekiaby, M. (2013). The platelet-cancer loop. Eur. J. Intern. Med. 24, 393-400. doi: 10.1016/j.ejim.2013.01.017
55. Gould, T. J., Vu, T. T., Swystun, L. L., Dwivedi, D. J., Mai, S. H., Weitz, J. I., et al. (2014). Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 34, 1977-1984. doi: 10.1161/ATVBAHA.114.304114
56. Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., and Benezra, R. (2011). Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20, 300-314. doi: 10.1016/j.ccr.2011.08.012
57. Grignani, G., Pacchiarini, L., Ricetti, M. M., Dionigi, P., Jemos, V., Zucchella, M., et al. (1989). Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues. Invasion Metastasis 9, 298-309
58. Guillem-Llobat, P., Dovizio, M., Bruno, A., Ricciotti, E., Cufino, V., Sacco, A., et al. (2016). Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget 7, 32462-32477. doi: 10.18632/oncotarget.8655
59. Hanna, D. L., White, R. H., and Wun, T. (2013). Biomolecular markers of cancer-associated thromboembolism. Crit. Rev. Oncol. Hematol. 88, 19-29. doi: 10.1016/j.critrevonc.2013.02.008
60. Herbert, J. M., Dupuy, E., Laplace, M. C., Zini, J. M., Bar Shavit, R., and Tobelem, G. (1994). Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem. J. 303, 227-231. doi: 10.1042/bj3030227
61. Hisada, Y., Geddings, J. E., Ay, C., and Mackman, N. (2015). Venous thrombosis and cancer: from mouse models to clinical trials. J. Thromb. Haemost. 13, 1372-1382. doi: 10.1111/jth.13009
62. Honn, K. V., Tang, D. G., and Crissman, J. D. (1992). Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 11, 325-351. doi: 10.1007/BF01307186
63. Houng, A. K., Maggini, L., Clement, C. Y., and Reed, G. L. (1997). Identification and structure of activated-platelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets. Eur. J. Biochem. 243, 209-218. doi: 10.1111/j.1432-1033.1997.0209a.x
64. Hron, G., Kollars, M., Weber, H., Sagaster, V., Quehenberger, P., Eichinger, S., et al. (2007). Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb. Haemost. 97, 119-123. doi: 10.1160/TH06-03-0141
65. Huang, Z., Miao, X., Luan, Y., Zhu, L., Kong, F., Lu, Q., et al. (2015). PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate. J. Thromb. Haemost. 13, 465-476. doi: 10.1111/jth.12815
66. Hunter, K. W., Crawford, N. P. S., and Alsarraj, J. (2008). Mechanisms of metastasis. Breast Cancer Res. 10(Suppl. 1):S2. doi: 10.1186/bcr1988
67. Ishizuka, M., Nagata, H., Takagi, K., Iwasaki, Y., and Kubota, K. (2013). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br. J. Cancer 109, 401-407. doi: 10.1038/bjc.2013.350
68. Ishizuka, M., Oyama, Y., Abe, A., and Kubota, K. (2014). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J. Surg. Oncol. 110, 935-941. doi: 10.1002/jso.23753
69. Italiano, J. E. J., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., et al. (2008). Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet granules and differentially released. Blood 111, 1227-1233. doi: 10.1182/blood-2007-09-113837
70. Janowska-Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez-Curtis, L., Machalinski, B., Ratajczak, J., et al. (2005). Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer 113, 752-760. doi: 10.1002/ijc.20657
71. Ji, Y., Sheng, L., Du, X., Qiu, G., and Su, D. (2015). Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients. Platelets 26, 138-142. doi: 10.3109/09537104.2014.888547
72. Jia, J., Zheng, X., Chen, Y., Wang, L., Ye, X., Chen, Y., et al. (2015). Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol. 36, 9319-9325. doi: 10.1007/s13277-015-3667-9
73. Jonnalagadda, D., Izu, L. T., and Whiteheart, S. W. (2012). Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 120, 5209-5216. doi: 10.1182/blood-2012-07-445080
74. Jurasz, P., Alonso-Escolano, D., and Radomski, M. W. (2004). Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br. J. Pharmacol. 143, 819-826. doi: 10.1038/sj.bjp.0706013
75. Jurk, K., and Kehrel, B. E. (2005). Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 31, 381-392. doi: 10.1055/s-2005-916671
76. Kadlec, B., Skrickova, J., Merta, Z., Dusek, L., and Jarkovsky, J. (2014). The incidence and predictors of thromboembolic events in patients with lung cancer. Sci. World J. 2014:125706. doi: 10.1155/2014/125706
77. Kasirer-Friede, A., Kahn, M. L., and Shattil, S. J. (2007). Platelet integrins and immunoreceptors. Immunol. Rev. 218, 247-264. doi: 10.1111/j.1600-065X.2007.00532.x
78. Key, N. S., Khorana, A. A., Mackman, N., McCarty, O. J. T., White, G. C., Francis, C. W., et al. (2016). Thrombosis in cancer: research priorities identified by a national cancer institute/national heart, lung, and blood institute strategic working group. Cancer Res. 76, 1-5. doi: 10.1158/0008-5472.CAN-15-3100
79. Khorana, A. A., Francis, C. W., Culakova, E., and Lyman, G. H. (2005). Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104, 2822-2829. doi: 10.1002/cncr.21496
80. Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., and Lyman, G. H. (2007). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J. Thromb. Haemost. 5, 632-634. doi: 10.1111/j.1538-7836.2007.02374.x
81. Khorana, A. A., Francis, C. W., Menzies, K. E., Wang, J.-G., Hyriens, O., Hathcock, J., et al. (2008). Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J. Thromb. Haemost. 6, 1983-1985. doi: 10.1111/j.1538-7836.2008.03156.x
82. Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., et al. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16, 116-122. doi: 10.1038/nm.2072
83. Kim, H. J., Choi, G.-S., Park, J. S., Park, S. Y., Kawai, K., and Watanabe, T. (2015). Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: predicting pathologic tumor response and oncologic outcome. Ann. Surg. Oncol. 22, 513-519. doi: 10.1245/s10434-014-3988-8
84. Kim, H. K., Song, K. S., Chung, J. H., Lee, K. R., and Lee, S. N. (2004). Platelet microparticles induce angiogenesis in vitro. Br. J. Haematol. 124, 376-384. doi: 10.1046/j.1365-2141.2003.04773.x
85. Kim, J., and Bae, J.-S. (2016). Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016, 11. doi: 10.1155/2016/6058147
86. Kim, M., Chang, H., Yang, H. C., Kim, Y. J., Lee, C.-T., Lee, J.-H., et al. (2014). Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J. Surg. Oncol. 12:37. doi: 10.1186/1477-7819-12-37
87. Kitagawa, H., Yamamoto, N., Yamamoto, K., Tanoue, K., Kosaki, G., and Yamazaki, Y. (1989). Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and-independent platelet aggregations induced by tumor cells. Cancer Res. 49, 537-541
88. Kohler, S., Ullrich, S., Ruchter, U., and Schumacher, U. (2010). E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br. J. Cancer 102, 602-609. doi: 10.1038/sj.bjc.6605492
89. Kolarova, H., Klinke, A., Kremserova, S., Adam, M., Pekarova, M., Baldus, S., et al. (2013). Myeloperoxidase induces the priming of platelets. Free Radic. Biol. Med. 61, 357-369. doi: 10.1016/j.freeradbiomed.2013.04.014
90. Kong, D., Wang, Z., Sarkar, S. H., Li, Y., Banerjee, S., Saliganan, A., et al. (2008). Platelet-derived growth factor-d overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26, 1245-1435. doi: 10.1634/stemcells.2007-1076
91. Kopp, H. G., Placke, T., and Salih, H. R. (2009). Platelet-derived transforming growth factor-B down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 69, 7775-7783. doi: 10.1158/0008-5472.CAN-09-2123
92. Kourelis, T. V., Wysonkinska, E. M., Wang, Y., Yang, P., Mansfield, A. S., and Tafur, A. J. (2014). Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer 86, 358-362. doi: 10.1016/j.lungcan.2014.10.003
93. Kral, J. B., Schrottmaier, W. C., Salzmann, M., and Assinger, A. (2016). Platelet interaction with innate immune cells. Transfus. Med. Hemother. 43, 78-88. doi: 10.1159/000444807
94. LaBarge, M. A. (2010). The difficulty of targeting cancer stem cell niches. Clin. Cancer Res. 16, 3121-3129. doi: 10.1158/1078-0432.CCR-09-2933
95. LaBarge, M. A., Petersen, O. W., and Bissell, M. J. (2007). Of microenvironments and mammary stem cells. Stem Cell Rev. 3, 137-146. doi: 10.1007/s12015-007-0024-4
96. Labelle, M., and Hynes, R. O. (2012). The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2, 1091-1099. doi: 10.1158/2159-8290.CD-12-0329
97. Labelle, M., Begum, S., and Hynes, R. O. (2011). Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576-590. doi: 10.1016/j.ccr.2011.09.009
98. Lal, I., Dittus, K., and Holmes, C. E. (2013). Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 15:207. doi: 10.1186/bcr3425
99. Landry, P., Plante, I., Ouellet, D. L., Perron, M. P., Rousseau, G., and Provost, P. (2009). Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 16, 961-966. doi: 10.1038/nsmb.1651
100. Larrick, J. W., and Wright, S. C. (1990). Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 4, 3215-3223
101. Laubli, H., and Borsig, L. (2010). Selectins promote tumor metastasis. Semin. Cancer Biol. 20, 169-177. doi: 10.1016/j.semcancer.2010.04.005
102. Leblanc, R., and Peyruchaud, O. (2015). New insights into the autotaxin/LPA axis in cancer development and metastasis. Exp. Cell Res. 333, 183-189. doi: 10.1016/j.yexcr.2014.11.010
103. Leblanc, R., and Peyruchaud, O. (2016). Metastasis: new functional implications of platelets and megakaryocytes. Blood 128, 24-31. doi: 10.1182/blood-2016-01-636399
104. Li, N. (2016). Platelets in cancer metastasis: to help the "villian" to do evil. Int. J. Cancer 138, 2078-2087. doi: 10.1002/ijc.29847
105. Li, Y., and Kowdley, K. V. (2012). MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics 10, 246-253. doi: 10.1016/j.gpb.2012.07.005
106. Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., et al. (2001). Activated platelets mediate inflammatory signaling by regulated interleukin 1b synthesis. J. Cell Biol. 154, 485-490. doi: 10.1083/jcb.200105058
107. Lonsdorf, A. S., Kramer, B. F., Fahrleitner, M., Schonberger, T., Gnerlich, S., Ring, S., et al. (2012). Engagement of αIIbβ3 (GPIIb/IIIa) with αIIβ3 integrin mediates interaction of melanoma cells with platelets. J. Biol. Chem. 287, 2168-2178. doi: 10.1074/jbc. M111.269811
108. Lou, X.-L., Sun, J., Gong, S.-Q., Yu, X.-F., Gong, R., and Deng, H. (2015). Interaction between circulating cancer cells and platelets: clinical implication. Chin. J. Cancer Res. 27, 450-460. doi: 10.3978/j.issn.1000-9604.2015.04.10
109. Ma, L., Perini, R., McKnight, W., Dicay, M., Klein, A., Hollenberg, M. D., et al. (2005). Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc. Natl. Acad. Sci. U.S.A. 102, 216-220. doi: 10.1073/pnas.0406682102
110. Machlus, K. R., and Italiano, J. E. Jr. (2013). The incredible journey: from megakaryocyte development to platelet formation. J. Cell Biol. 201, 785-796. doi: 10.1083/jcb.201304054
111. Mackman, N. (2008). Triggers, targets and treatments for thrombosis. Nature 451, 914-918. doi: 10.1038/nature06797
112. Manly, D. A., Wang, J., Glover, S. L., Kasthuri, R., Liebman, H. A., Key, N. S., et al. (2010). Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb. Res. 125, 511-512. doi: 10.1016/j.thromres.2009.09.019
113. Martinez, M. C., and Andriantsitohaina, R. (2011). Microparticles in angiogenesis: therapeutic potential. Circ. Res. 109, 110-119. doi: 10.1161/CIRCRESAHA.110.233049
114. Mazzarello, P., Calligaro, A. L., and Calligaro, A. (2001). Giulio Bizzozero: a pioneer of cell biology. Nat. Rev. Mol. Cell Biol. 2, 776-784. doi: 10.1038/35096085
115. McManus, D. D., and Freedman, J. E. (2015). MicroRNAs in platelet function and cardiovascular disease. Nat. Rev. Cardiol. 12, 711-717. doi: 10.1038/nrcardio.2015.101
116. Mege, D., Mezouar, S., Dignat-George, F., Panicot-Dubois, L., and Dubois, C. (2016). Microparticles and cancer thrombosis in animal models. Thromb. Res. 140S1, S21-S26. doi: 10.1016/S0049-3848(16)30094-9
117. Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., and Honn, K. V. (2014). Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 33, 231-269. doi: 10.1007/s10555-014-9498-0
118. Messager, M., Neofytou, K., Chaudry, M. A., and Allum, W. H. (2015). Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: a retrospective monocentric study on 153 patients. Eur. J. Surg. Oncol. 41, 1316-1323. doi: 10.1016/j.ejso.2015.06.007
119. Miglani, R. K., Bhateja, N., Bhat, R. S., and Kumar, K. V. A. (2013). Diagnostic role of platelet lymphocyte ratio (PLR) in pancreatic head masses. Indian J. Surg. 75, 4-9. doi: 10.1007/s12262-012-0443-6
120. Mills, G. B., and Moolenaar, W. H. (2003). The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 583-591. doi: 10.1038/nrc1143
121. Miyashita, T., Tajima, H., Makino, I., Nakagawara, H., Kitagawa, H., Fushida, S., et al. (2015). Metastasis-promoting role of extravasated platelet activation in tumor. J. Surg. Res. 193, 289-294. doi: 10.1016/j.jss.2014.07.037
122. Moschini, M., Suardi, N., Pellucchi, F., Rocchini, L., La Croce, G., Capitanio, U., et al. (2014). Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma. Anticancer Res. 34, 3225-3230
123. Nakahira, M., Sugasawa, M., Matsumura, S., Kuba, K., Ohba, S., Hayashi, T., et al. (2016). Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 273, 3863-3867. doi: 10.1007/s00405-016-3996-3
124. Nieswandt, B., Hafner, M., Echtenacher, B., and Mannel, D. N. (1999). Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59, 1295-1300
125. Nilsson, R. J. A., Balaj, L., Hulleman, E., van Rijn, S., Pegtel, D. M., Walraven, M., et al. (2011). Blood platelets contain tumor-derived RNA biomarkers. Blood 118, 3680-3683. doi: 10.1182/blood-2011-03-344408
126. Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., et al. (2015). Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget 7, 1066-1075. doi: 10.18632/oncotarget.6279
127. Orellana, R., Kato, S., Erices, R., Bravo, M. L., Gonzalez, P., Oliva, B., et al. (2015). Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer 15:290. doi: 10.1186/s12885-015-1304-z
128. Owens, A. P. III, and Mackman, N. (2011). Microparticles in hemostasis and thrombosis. Circ. Res. 108, 1284-1297. doi: 10.1161/CIRCRESAHA.110.233056
129. Palis, J., and Segel, G. B. (2016). "Hematology of the fetus and newborn". in Williams Hematology, eds K. Kaushansky, M. A. Lichtman, J. T. Prchal, M. M. Levi, O. W. Press, L. J. Burns, and M. A. Caligiuri (New York, NY: McGraw-Hill), 99-117
130. Pang, J. H., Coupland, L. A., Freeman, C., Chong, B. H., and Parish, C. R. (2015). Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Clin. Exp. Metastasis 32, 495-505. doi: 10.1007/s10585-015-9722-5
131. Perez-Callejo, D., Romero, A., Provencio, M., and Torrente, M. (2016). Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring. Transl. Lung Cancer Res. 5, 455-465. doi: 10.21037/tlcr.2016.10.07
132. Philippe, C., Philippe, B., Fouqueray, B., Perez, J., Lebret, M., and Baud, L. (1993). Protection from tumor necrosis factor-mediated cytolysis by platelets. Am. J. Pathol. 143, 1713-1723
133. Phillips, K. G., Lee, A. M., Tormoen, G. W., Rigg, R. A., Kolatkar, A., Luttgen, M., et al. (2015). The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation. Am. J. Physiol. Cell Physiol. 308, C229-C236. doi: 10.1152/ajpcell.00315.2014
134. Placke, T., Kopp, H. G., and Salih, H. R. (2011). Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun. 3, 371-382. doi: 10.1159/000323936
135. Placke, T., Orgel, M., Schaller, M., Jung, G., Rammensee, H. G., Kopp, H. G., et al. (2012). Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 72, 440-448. doi: 10.1158/0008-5472.CAN-11-1872
136. Plé, H., Landry, P., Benham, A., Coarfa, C., Gunaratne, P. H., and Provost, P. (2012). The repertoire and features of human platelet microRNAs. PLoS ONE 7:e50746. doi: 10.1371/journal.pone.0050746
137. Polgar, J., Clemetson, J. M., Kehrel, B. E., Wiedemann, M., Magnenat, E. M., Wells, T. N. C., et al. (1997). Platelet activation and signal transduction by convulxin, a C-type lectin from crotalus durissus terrificus (Tropical Rattlesnake) venom via the p62/GPVI collagen receptor. J. Biol. Chem. 272, 13576-13583. doi: 10.1074/jbc.272.21.13576
138. Prokopi, M., Pula, G., Mayr, U., Devue, C., Gallagher, J., Xiao, Q., et al. (2009). Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114, 723-732. doi: 10.1182/blood-2009-02-205930
139. Qi, C., Wei, B., Zhou, W., Yang, Y., Li, B., Guo, S., et al. (2015). P-selectin-mediated platelet adhesion promotes tumor growth. Oncotarget 6, 6584-6596. doi: 10.18632/oncotarget.3164
140. Radisky, D. C., and LaBarge, M. A. (2008). Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2, 511-512. doi: 10.1016/j.stem.2008.05.007
141. Rowley, J. W., Chappaz, S., Corduan, A., Chong, M. M. W., Campbell, R., Khoury, A., et al. (2016). Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood 127, 1743-1751. doi: 10.1182/blood-2015-07-661371
142. Sabrkhany, S., Griffioen, A. W., and Oude Egbrink, M. G. A. (2011). The role of blood platelets in tumor angiogenesis. Biochim. Biophys. Acta 1815, 189-196. doi: 10.1016/j.bbcan.2010.12.001
143. Sanchez-Salcedo, P., de-Torres, J. P., Martinez-Urbistondo, D., Gonzalez-Gutierrez, J., Berto, J., Campo, A., et al. (2016). The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development. Lung Cancer 97, 28-34. doi: 10.1016/j.lungcan.2016.04.010
144. Schumacher, D., Strilic, B., Sivaraj, K. K., Wettschureck, N., and Offermanns, S. (2013). Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 Receptor. Cancer Cell 24, 130-137. doi: 10.1016/j.ccr.2013.05.008
145. Schwertz, H., Tolley, N. D., Foulks, J. M., Denis, M. M., Risenmay, B. W., Buerke, M., et al. (2006). Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets. J. Exp. Med. 203, 2433-2440. doi: 10.1084/jem.20061302
146. Seliger, B. (2008). Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunol. Immunother. 57, 1719-1726. doi: 10.1007/s00262-008-0515-4
147. Seliger, B. (2014). The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors. J. Immunotoxicol. 11, 308-310. doi: 10.3109/1547691X.2013.875084
148. Semple, J. W., Italiano, J. E., and Freedman, J. (2011). Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274. doi: 10.1038/nri2956
149. Shau, H., Roth, M. D., and Golub, S. H. (1993). Regulation of natural killer function by nonlymphoid cells. Nat. Immun. 12, 235-249
150. Shoji, M., Hancock, W. W., Abe, K., Micko, C., Casper, K. A., Baine, R. M., et al. (1998). Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol. 152, 399-411
151. Sierko, E., and Wojtukiewicz, M. Z. (2004). Platelets and angiogenesis in malignancy. Semin. Thromb. Hemost. 30, 95-108. doi: 10.1055/s-2004-822974
152. Sola-Visner, M. (2012). Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Am. Soc. Hematol. Educ. Prog. 2012, 506-511. doi: 10.1182/asheducation-2012.1.506
153. Sørensen, A. L., Rumjantseva, V., Nayeb-Hashemi, S., Clausen, H., Hartwig, J. H., Wandall, H. H., et al. (2009). Role of sialic acid for platelet life span: exposure of β-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 114, 1645-1654. doi: 10.1182/blood-2009-01-199414
154. Sorensen, H. T., Mellemkjaer, L., Olsen, J. H., and Baron, J. A. (2000). Prognosis of cancers associated with venous thromboembolism. N. Engl. J. Med. 343, 1846-1850. doi: 10.1056/NEJM200012213432504
155. Stegner, D., Dutting, S., and Nieswandt, B. (2014). Mechanistic explanation for platelet contribution to cancer metastasis. Thromb. Res. 133, S149-S157. doi: 10.1016/S0049-3848(14)50025-4
156. Stone, J. P., and Wagner, D. D. (1993). P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J. Clin. Invest. 92, 804-813. doi: 10.1172/JCI116654
157. Suzuki-Inoue, K., Fuller, G. L., Garcia, A., Eble, J. A., Pohlmann, S., Inoue, O., et al. (2006). A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 17, 542-549. doi: 10.1182/blood-2005-05-1994
158. Talmadge, J. E., Meyers, K. M., Prieur, D. J., and Starkey, J. R. (1980). Role of NK cells in tumor growth and metastasis in beige mice. Nature 284, 622-624. doi: 10.1038/284622a0
159. Thomas, G. M., Panicot-Dubois, L., Lacroix, R., Dignat-George, F., Lombardo, D., and Dubois, C. (2009). Cancer cell-serived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J. Exp. Med. 206, 1913-1927. doi: 10.1084/jem.20082297
160. van den Berg, Y. W., Osanto, S., Reitsma, P. H., and Versteeg, H. H. (2012). The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 119, 924-932. doi: 10.1182/blood-2011-06-317685
161. Varki, A. (2007). Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110, 1723-1729. doi: 10.1182/blood-2006-10-053736
162. Varon, D., Hayon, Y., Dashevsky, O., and Shai, E. (2012). Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb. Res. 1300, S98-S99. doi: 10.1016/j.thromres.2012.08.289
163. Verheul, H. M., Hoekman, K., Broxterman, H. J., van der Valk, P., Kakkar, A. K., and Pinedo, H. M. (2000). Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin. Cancer Res. 6, 166-171
164. Verheul, H. M., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J., et al. (1997). Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 3, 2187-2190
165. Versteeg, H. H. (2015). Tissue factor: old and new links with cancer biology. Semin. Thromb. Hemost. 41, 747-755. doi: 10.1055/s-0035-1556048
166. Voutsadakis, I. A. (2014). Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J. Gastrointest. Oncol. 6, 34-40. doi: 10.4251/wjgo.v6.i2.34
167. Wang, Y., Sun, Y., Li, D., Zhang, L., Wang, K., Zuo, Y., et al. (2013). Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS ONE 8:e80780. doi: 10.1371/journal.pone.0080780
168. Wang, Y., Xu, F., Pan, J., Zhu, Y., Shao, X., Sha, J., et al. (2016). Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy. BMC Cancer 16:329. doi: 10.1186/s12885-016-2363-5
169. Watt, D. G., Proctor, M. J., Park, J. H., Horgan, P. G., and McMillan, D. C. (2015). The neutrophil-platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers. PLoS ONE 10:e0142159. doi: 10.1371/journal.pone.0142159
170. Weyrich, A. S., Dixon, D. A., Pabla, R., Elstad, M. R., McIntyre, T. M., Prescott, S. M., et al. (1998). Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. U.S.A. 95, 5556-5561. doi: 10.1073/pnas.95.10.5556
171. Wiltrout, R. H., Herberman, R. B., Zhang, S. R., Chirigos, M. A., Ortaldo, J. R., Green, K. M. Jr., et al. (1985). Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J. Immunol. 134, 4267-4275
172. Witz, I. P. (2008). The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev. 27, 19-30. doi: 10.1007/s10555-007-9101-z
173. Worth, R. G., Chien, C. D., Chien, P., Reilly, M. P., McKenzie, S. E., and Schreiber, A. D. (2006). Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp. Hematol. 34, 1490-1495. doi: 10.1016/j.exphem.2006.06.015
174. Wright, J. H. (1910). The histogenesis of the blood platelets. J. Morphol. 21, 263-278. doi: 10.1002/jmor.1050210204
175. Yeaman, M. R. (2014). Platelets: at the nexus of antimicrobial defence. Nat. Rev. Microbiol. 12, 426-437. doi: 10.1038/nrmicro3269
176. Yu, J. L., and Rak, J. W. (2004). Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J. Thromb. Haemost. 2, 2065-2067. doi: 10.1111/j.1538-7836.2004.00972.x
177. Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 3369, 580-584. doi: 10.1126/science.1228522
178. Zhang, H., Zhang, L., Zhu, K., Shi, B., Yin, Y., Zhu, J., et al. (2015). Prognostic significance of combination of preoperative platelet count and neutrophillymphocyte ratio (COP-NLR) in patients with non-small cell lung cancer: based on a large cohort study. PLoS ONE 10:e0126496. doi: 10.1371/journal.pone.0126496
179. Zhang, S., Zhang, S., Hu, L., Zhai, L., Xue, R., Ye, J., et al. (2015). NOD2 receptor is expressed in platelets and enhances platelet activation and thrombosis. Circulation 131, 1160-1170. doi: 10.1161/CIRCULATIONAHA.114.013743
180. Zhang, Y., Jiang, C., Li, J., Sun, J., and Qu, X. (2015). Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Clin. Transl. Oncol. 17, 810-818. doi: 10.1007/s12094-015-1310-2
181. Zhou, X., Du, Y., Huang, Z., Xu, J., Qiu, T., Wang, J., et al. (2014). Prognostic value of PLR in various cancers: a meta-analysis. PLoS ONE 9:e101119. doi: 10.1371/journal.pone.0101119
182. Zimmerman, G. A., and Weyrich, A. S. (2008). Signal-dependent protein synthsis by activated platelets. Arterioscler. Thromb. Vasc. Biol. 28, s17-s24. doi: 10.1161/ATVBAHA.107.160218
183. Zucchella, M., Dezza, L., Pacchiarini, L., Meloni, F., Tacconi, F., Bonomi, E., et al. (1989). Human tumor cells cultured "in vitro" activate platelet function by producing ADP or thrombin. Haematologica 74, 541-545